Christine Maheu, RN, PhD
Professor, Ingram School of Nursing
680 Sherbrooke Street West, Montreal, QC, H3A 2M7, Office 1809
christine.maheu [at] mcgill.ca
514-398-1906
Christine Maheu, RN, PhD, is a Professor at the Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, and a clinician-scientist in psychosocial oncology. Her internationally recognized program of research focuses on cancer survivorship, fear of cancer recurrence and return to work after cancer. She is Co-Director of the Cancer and Work and FORT (Fear of Recurrence Therapy) Lab and Principal Investigator within the Cancer Research Program at the Research Institute of the McGill University Health Centre.
Professor Maheu is recognized for developing and evaluating innovative, theory-driven interventions that improve psychosocial and functional outcomes among cancer survivors. She co-developed FORT, one of the most rigorously tested interventions for fear of cancer recurrence, and led the development of iCanWork, Canada’s first structured return-to-work intervention for cancer survivors. She also developed the Cancer and Work Scale, a validated assessment tool now used in survivorship research and practice.
A major focus of her work is knowledge translation and implementation science. She leads Cancer and Work, a bilingual national platform recognized by the Canadian Cancer Society and designated a Leading Practice by the Health Standards Organization in partnership with BC Cancer. The platform reaches over 1,000 users weekly and supports survivors, employers, insurers, and healthcare professionals through evidence-based resources, training modules, and practical tools. Building on this work, Prof. Maheu recently co-launched the Canadian Cancer & Work Charter in partnership with the Quebec Cancer Coalition and the Canadian Pensions and Benefits Institute, a pan-Canadian initiative aimed at helping employers better support employees affected by cancer through workplace accommodations, job retention, and return-to-work practices.
Prof. Maheu has secured over $7 million in research funding as Principal Investigator, Co-Principal Investigator, or Co-Investigator from agencies including CIHR, the Canadian Cancer Society, FRQS, CPAC, and the Quebec Breast Cancer Foundation. Her work has received national and international recognition for innovation, public engagement, and impact on cancer survivorship care.